Skip to main content

Table 2 MAP and HR at four time points

From: Effect of pre-use of Dexmedetomidine on the effective inhibitory dose of remimazolam tosilate on positive cardiovascular response in double-lumen endobronchial intubation: a clinical study

 

Time Point

Group A

Group A-O

Group A-Y

Group B

Group C

MAP(mmHg)

T1

96.4 ± 8.3a

99.0 ± 8.2

94.7 ± 8.1

95.2 ± 7.0a

99.4 ± 6.4a

 

T2

/

/

/

88.1 ± 9.0

94.8 ± 9.7

 

T3

82.2 ± 8.2

83.7 ± 8.8

81.1 ± 7.8

83.1 ± 10.3

91.1 ± 10.5

 

T4

101.7 ± 13.9

105.4 ± 13.2

99.3 ± 14.1

99.7 ± 14.9

99.6 ± 10.3

 h(bpm)

T1

79.1 ± 10.6a

78.8 ± 8.7

79.3 ± 11.8

77.1 ± 8.4a

76.0 ± 8.7a

 

T2

/

/

/

66.3 ± 8.7

62.8 ± 6.7

 

T3

76.3 ± 11.0

76.6 ± 9.3

76.0 ± 12.2

66.8 ± 9.6

64.0 ± 7.6

 

T4

90.8 ± 12.2

92.6 ± 12.1

89.5 ± 12.3

81.2 ± 10.4

80.0 ± 10.9

  1. MAP: mean arterial pressure, HR: heart rate; a P>0.05 vs. T1.